(Q41190819)

28 September 2017

Health-related quality of life in men with erectile dysfunction (English)

1 reference

28 September 2017

1 reference

M S Litwin

1

1 reference

28 September 2017

R J Nied

series ordinal

2

1 reference

28 September 2017

N Dhanani

series ordinal

3

1 reference

28 September 2017

1 March 1998

1 reference

Journal of General Internal Medicine

28 September 2017

1 reference

28 September 2017

13

1 reference

28 September 2017

3

1 reference

28 September 2017

159-166

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1525-1497.1998.00050.x

28 September 2017

0 references

cites work

Practice trends of American urologists in the treatment of impotence, incontinence and infertility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Measuring health-related quality of life

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Measuring health related quality of life in men with prostate cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Patient acceptance of and satisfaction with vasoactive intracavernous pharmacotherapy for impotence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Development of a comprehensive quality of life measurement tool: CARES.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Sexuality and aging in male veterans: a cross-sectional study of interest, ability, and activity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Twelve-month comparison of two treatments for erectile dysfunction: Self-injection versus external vacuum devices

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

The MOS 36-ltem Short-Form Health Survey (SF-36)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Long-term efficacy of a new formulation of prostaglandin E1 as treatment for erectile failure

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Quality-of-life outcomes in men treated for localized prostate cancer.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496922

The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1998.00050.X

Coefficient alpha and the internal structure of tests

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1998.00050.X

Assessment of quality-of-life outcomes

21 January 2018

1 reference

12 December 2020

Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery

1 reference

12 December 2020

Why do so many people drop out from auto-injection therapy for impotence?

1 reference

12 December 2020

CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument

1 reference

12 December 2020

Patient satisfaction with pharmacologic erection program

1 reference

12 December 2020

The CARES: a generic measure of health-related quality of life for patients with cancer

1 reference

12 December 2020

Pathophysiology of erectile dysfunction

1 reference

12 December 2020

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

12 December 2020

High attrition rate with intracavernous injection of prostaglandin E1 for impotency

1 reference

12 December 2020

Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses

1 reference

12 December 2020

10.1046/J.1525-1497.1998.00050.X

Identifiers

DOI

1 reference

Dimensions Publication ID

28 September 2017

0 references

1 reference

28 September 2017

PubMed publication ID

9541372

1 reference